Cargando…

Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients

Detalles Bibliográficos
Autores principales:	Zandman-Goddard, G, Blank, M, Langevitz, P, Pras, M, Levy, Y, Witte, T, Doria, A, Rovensky, J, Shoenfeld, Y
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833599/ http://dx.doi.org/10.1186/ar662

Ejemplares similares

Elevated titers of anti-ribosomal-P antibodies in systemic lupus erythematosus
por: Zandman-Goddard, G, et al.
Publicado: (2005)

Nucleosome binding by serum amyloid P component from SLE patients
por: Heegaard, NHH, et al.
Publicado: (2001)

The Homogeneous Multiplexed System-a New Method for Autoantibody Profile in Systemic Lupus Erythematosus
por: Zandman-Goddard, Gisele, et al.
Publicado: (2005)

Serum amyloid P component (SAP) binds to late apoptotic cells and mediates their phagocytosis by macrophages
por: Bijl, M, et al.
Publicado: (2002)

Acceleration of apoptotic cells clearance by macrophages upon exposure to serum amyloid P component and its synthetic derivates
por: Slutzky, L, et al.
Publicado: (2005)

Signalling via T cell receptor (TCR) in patients with SLE
por: Cebecauer, M, et al.
Publicado: (2001)

Serum amyloid-p (SAP), a potential biomarker for Down syndrome fetuses prevention in maternal plasma
por: Anagnostopoulos, Athanasios, et al.
Publicado: (2014)

Modulation of fibrin clot formation by human serum amyloid P component (SAP) and heparin
Publicado: (1983)

Serum Amyloid P Component (SAP)-Like Protein From Botryllid Ascidians Provides a Clue to Amyloid Function
por: Scofield, V. L., et al.
Publicado: (1992)

Biologic therapy for autoimmune diseases: an update
por: Rosman, Ziv, et al.
Publicado: (2013)

SLE: insights from array-based proteomics
por: Wu, T, et al.
Publicado: (2012)

New Therapeutic Strategies for Systemic Sclerosis—a Critical Analysis of the Literature
por: Zandman-Goddard, Gisele, et al.
Publicado: (2005)

Prolactin and Autoimmunity
por: Borba, Vânia Vieira, et al.
Publicado: (2018)

The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti- β2GPI Abs induced by common bacteria
por: Blank, M, et al.
Publicado: (2001)

The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis
por: Shovman, O., et al.
Publicado: (2005)

Functional Characterization of Serum Amyloid P Component (SAP) in Host Defense against Bacterial Infection in a Primary Vertebrate
por: Li, Jiadong, et al.
Publicado: (2022)

The role of DNA in the pathogenesis of SLE
por: Pisetsky, DS
Publicado: (2001)

IMMUNOLOGIC STUDIES OF THE MAJOR NONIMMUNOGLOBULIN PROTEIN OF AMYLOID : I. IDENTIFICATION AND PARTIAL CHARACTERIZATION OF A RELATED SERUM COMPONENT
por: Levin, Mark, et al.
Publicado: (1973)

Genetic analysis of the pentraxin genes in SLE
por: Russell, AI, et al.
Publicado: (2001)

Vasculitis and Systemic Lupus Erythematous (SLE)
por: Cortis, Elisabetta, et al.
Publicado: (2015)

T lymphocytes of patients with SLE lack Stat4
por: Aringer, M, et al.
Publicado: (2001)

SLE risk alleles and cell development and activation
por: Kim, SJ, et al.
Publicado: (2012)

Clinical impact of biologic therapy in the treatment of SLE
por: Wallace, Daniel J
Publicado: (2013)

Neuropsychiatric lupus: a mosaic of clinical presentations
por: Kivity, Shaye, et al.
Publicado: (2015)

Effect of pregnancy on serum cytokines in SLE patients
por: Doria, Andrea, et al.
Publicado: (2012)

The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti-β2GPI antibodies induced by common bacteria
por: Blank, M, et al.
Publicado: (2003)

Neuropsychiatric events in SLE: determination of attribution and assessment of outcome
por: Hanly, JG
Publicado: (2012)

PROMISSE: progress in understanding pregnancy complications in patients with SLE
por: Salmon, JE
Publicado: (2012)

The use of Ribomunyl(®) in the immunomodulatory treatment of rats with adjuvant arthritis
por: Rovenský, J, et al.
Publicado: (2001)

B cells at the adaptive-innate immune system interface in SLE
por: Anolik, JH, et al.
Publicado: (2012)

Regulatory natural autoantibodies suppress inflammation and SLE disease activity
por: Silverman, GJ, et al.
Publicado: (2012)

Hydroxychloroquine: From Malaria to Autoimmunity
por: Ben-Zvi, Ilan, et al.
Publicado: (2011)

Variation of results of the SMR using APACHE II, APACHE III and SAPS II
por: Orellana, A, et al.
Publicado: (2003)

Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE
por: Pavlovic, Mirjana, et al.
Publicado: (2010)

MicroRNA-3148 modulates differential gene expression of the SLE-associated TLR7 variant
por: Deng, Y, et al.
Publicado: (2012)

The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome
por: Rosário, Cristina, et al.
Publicado: (2013)

The predictive value of serial acute physiology score (APS) and simplified acute physiology score II (SAPS II) in post-operative liver transplant patients
por: Arabi, Y, et al.
Publicado: (2000)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

Interplay of neutrophils and type I interferons in the development of end-organ damage in SLE
por: Kaplan, MJ
Publicado: (2012)

Relationship between systemic arterial pressure (SAP) and EtCO(2) in patients with hemorrhagic shock
por: Grmec, Š, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_u8hta2ibtqloufbkfjgo4lj4m5